Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FK463 Versus Fluconazole for Prophylaxis of Fungal Infections in Hematopoietic Stem Cell Transplant Patients
NCT00001937Phase 3Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of micafungin in fungal infection, sponsored by National Cancer Institute. Started Nov 1999; status: completed.
02
Drugs
micafungin
03
Conditions
fungal infection
Beyond the preview
Go deeper on NCT00001937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001937.